• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Point of Care (POC) Infectious Disease Diagnostic Testing Market

$2,995.00 – $5,995.00

Clear
SKU: KLI15640228 Categories: Diagnostics Market Research, Infectious Disease, Point-of-Care Diagnostics Pages: 129
  • Description
  • Table of Contents
  • Latest reports

Description

This Kalorama Information report, Point of Care Infectious Disease Diagnostic Testing provides market sizing and forecasts for the following disease areas
  • Influenza
  • STD
  • HIV
  • Hepatitis
  • Malaria
  • C. difficile
  • E. coli
  • H. pylori
  • Home Test/OTC
  • Others
Point of care testing market features competitors that are large major concerns as well as newer entrants and specialist players.  As part of its coverage, the report also profiles competitors in the market, including the following:
  • Abbott/Alere
  • Atlas Genetics Ltd.
  • Atlas Link Biotech Co., Ltd
  • Bhat Bio-Tech India Private Ltd. (BBI)
  • Biolytical Laboratories
  • Biomerica, Inc.
  • Boson Biotech Co. Ltd
  • Calypte Biomedical Corporation
  • Cepheid, Inc (Danaher)
  • Chembio Diagnostic Systems, Inc.
  • EKF Diagnostics Holdings Plc
  •  J. Mitra & Co Pvt. Ltd  
  •  Medmira, Inc  
  •  Meridian Bioscience, Inc  
  •  Opko Health, Inc
  • Orasure Technologies, Inc.  
  • Quidel Corporation  
  • Response Biomedical Corp  
  • Reszon Diagnostics International Sdn. Bhd.  
  • Rheonix, Inc  
  • Savyon Diagnostics  
  • Sekisui Diagnostics  
  • Trinity Biotech Plc  
  • Veredus Laboratories Pte Ltd  
  • Vircell  
  •  Wama Diagnostica

Table of Contents

1: EXECUTIVE SUMMARY

  • INTRODUCTION
  • SIZE AND GROWTH OF THE MARKET
  • REGIONAL ANALYSIS
  • COMPETITIVE ANALYSIS
  • SCOPE AND METHODOLOGY
  • TRENDS AFFECTING THE MARKET
  • COMPETITIVE OUTLOOK

2: INTRODUCTION AND OVERVIEW

  • OVERVIEW
  • Osteoporosis
  • Pregnancy and Fertility
  • POINT-OF-CARE DIAGNOSTICS TESTING
  • INDUSTRY REGULATIONS
  • TEST TYPES
  • Blood
  • Urine
  • Saliva
  • Hair
  • Optical Technologies
  • Breath
  • PRODUCTS IN INFECTIOUS DISEASE POC TESTING

3: POC INFECTIOUS DISEASE TESTING MARKET ANALYSIS

Table 3-1: Global POC Infectious Disease Testing Market Analysis: 2015-2022 (in millions of dollars at the manufacturer’s level)

Regional Analysis

Figure 3-1: POC Infectious Disease Testing Regional Market Analysis, 2017

POC Infectious Disease Self-Testing

Table 3-2: POC Infectious Disease Self-Testing Market Analysis, 204-2022 (in millions of dollars at the manufacturer’s level)

POC Infectious Disease Professional Testing

Table 3-3: POC Infectious Disease Professional Testing Market Analysis, 204-2022 (in millions of dollars at the manufacturer’s level)

POC Infectious Disease Testing by Disease Type

Table 3-4: Global POC Infectious Disease Revenues and Percent of Infectious Disease Market by Disease Type, 2017 (in milliions $)

COMPETITIVE ANALYSIS

Table 3-5: Global POC Infectious Disease Testing Market, Revenues and Market Share of Leading Suppliers, 2017 (in millions $)

Figure 3-2: Global POC Infectious Disease Test Manufacturers by Percent, 2017

4: CORPORATE PROFILES

ABBOTT LABORATORIES

  • Table 4-1: Abbott Corporate Summary
  • Company Overview
  • Product
  • Performance Review
  • Table 4-2: Abbott Revenues 2015-2017 (in millions $)
  • Alere Inc
  • Product
  • Performance Review
  • Table 4-3: Alere Revenue (2014-2017) ($ millions)

AQUILA DIAGNOSTIC SYSTEMS, INC

  • Table 4-4: Aquila Diagnostic Systems Summary
  • Company Overview
  • Products

ARKRAY

  • Table 4-5: Arkay Corporate Summary
  • Company Overview
  • Products

ARTRON LABORATORIES, INC

  • Table 4-6: Artron Laboratories Corporate Summary
  • Company Overview
  • Products

ATLAS GENETICS LTD.

  • Table 4-7: Atlas Genetics Corporate Summary
  • Company Overview
  • Products

ATLAS LINK BIOTECH CO., LTD

  • Table 4-8: Atlas Link Biotech Corporate Summary
  • Company Overview
  • Products

BHAT BIO-TECH INDIA PRIVATE LTD. (BBI)

  • Table 4-9: Bhat Bio-Tech India Private Corporate Summary
  • Company Overview
  • Products

BIOLYTICAL LABORATORIES

  • Table 4-10: bioLytical Laboratories Corporate Summary
  • Company Overview
  • Products

BIOMERICA, INC.

  • Table 4-11: Biomerica Corporate Summary
  • Company Overview
  • Products
  • Company Financials
  • Table 4-12: Biomerica Corporation Revenue (2014-2017) ($ millions)

BOSON BIOTECH CO. LTD

  • Table 4-13: Boson Biotech Corporate Summary
  • Company Overview
  • Products

CALYPTE BIOMEDICAL CORPORATION

  • Table 4-14: Calypte Biomedical Corporate Summary
  • Company Overview
  • Products

CEPHEID, INC (DANAHER)

  • Table 4-15: Cephid Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-16: Cepheid Revenues (2014-2017) ($ millions)

CHEMBIO DIAGNOSTIC SYSTEMS, INC.

  • Table 4-17: Chembio Diagnostic Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-18: Chembio Diagnostics Revenues (2014-2017) ($ millions)

EKF DIAGNOSTICS HOLDINGS PLC

  • Table 4-19: EKF Diagnostics Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-20: Eiken Chemical Revenues (2014-2017) ($ millions)
  1. MITRA & CO PVT. LTD

  • Table 4-21: J Mitra Corporate Summary
  • Company Overview
  • Products

MEDMIRA, INC

  • Table 4-21: MedMira Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-22: Medmira Revenues (2015-2017) ($ thousands)

MERIDIAN BIOSCIENCE, INC

  • Table 4-23: Meridian BioScience Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-24: Meridian Bioscience (2014-2017) ($ millions)

OPKO HEALTH, INC

  • Table 4-25: OPKO Health Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-26: OPKO Health Revenues (2014-2017) ($ millions)

ORASURE TECHNOLOGIES, INC.

  • Table 4-135: OraSure Technologies Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-136: OraSure Revenues (2014-2017) ($ millions)

QUIDEL CORPORATION

  • Table 4-143: Quidel Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-144: Quidel Revenues (2014-2017) ($ millions)

RESPONSE BIOMEDICAL CORP

  • Table 4-148: Response Biomedical Corporate Summary
  • Company Overview
  • Products

RESZON DIAGNOSTICS INTERNATIONAL SDN. BHD.

  • Table 4-149: Reszon Diagnostics Corporate Summary
  • Company Overview
  • Products

RHEONIX, INC

  • Table 4-150: Rheonix Corporate Summary
  • Company Overview
  • Products

SAVYON DIAGNOSTICS

  • Table 4-154: Savyon Diagnostics Corporate Summary
  • Company Overview
  • Products

SEKISUI DIAGNOSTICS

  • Table 4-155: Sekisui Diagnostics Corporate Summary
  • Company Overview
  • Products

TRINITY BIOTECH PLC

  • Table 4-164: Trinity Biotech Corporate Summary
  • Company Overview
  • Products
  • Performance Review
  • Table 4-165: Trinity Biotech Revenue (2014-2017) ($ millions)

VEREDUS LABORATORIES PTE LTD

  • Table 4-168: Veredus Labs Corporate Summary
  • Company Overview
  • Products

VIRCELL

  • Table 4-169: Vircell Corporate Summary
  • Company Overview
  • Products

WAMA DIAGNOSTICA

  • Table 4-170: WAMA Diagnostica Corporate Summary
  • Company Overview
  • Products

 

    30-Country In Vitro Diagnostic (IVD) Market Atlas, 2025 (June 2025 Update)
    June 25, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    June 24, 2025
    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025

Related products

  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Molecular Imaging Agents and Systems – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Biophotonics – A Strategic Assessment of Photonics Technologies for Biomedical Applications

    $2,995.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Point-of-Care Glucose Monitoring Market: World Market AnalysisDisruption in Healthcare: Amazon, Brexit, Trump, MACRA, Gig Workers, Aging –...
Scroll to top